Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 10 2024 - 2:14PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Amendment #7
Under the Securities and Exchange Act of 1934
Eiger
BioPharmaceuticals, Inc.
(Name of Issuer)
Common Stock
(Title of
Class of Securities)
28249U204
(CUSIP Number)
April 30, 2024
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
This Schedule is filed pursuant to Rule
13d-1(b)
The information required in the remainder of this cover page (except any items to which the form
provides a cross-reference) shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act.
CUSIP NO. 28249U105
|
|
|
|
|
|
|
1) |
|
Name of Reporting Person Ameriprise Financial,
Inc. S.S. or I.R.S. Identification No. of Above
Person IRS No. 13-3180631 |
2) |
|
Check the Appropriate Box if a
Member of a Group (a) ☐ (b) ☒*
* This filing describes the reporting persons relationship with other persons, but the reporting
person does not affirm the existence of a group. |
3) |
|
SEC Use Only
|
4) |
|
Citizenship or Place of
Organization
Delaware |
|
|
|
|
|
|
|
NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5) |
|
Sole Voting Power
0 |
|
6) |
|
Shared Voting Power
0 |
|
7) |
|
Sole Dispositive Power
0 |
|
8) |
|
Shared Dispositive Power
0 |
|
|
|
|
|
|
|
9) |
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0 |
10) |
|
Check if the Aggregate Amount
in Row (9) Excludes Certain Shares Not Applicable |
11) |
|
Percent of
Class Represented by Amount In Row (9) 0.00% |
12) |
|
Type of Reporting Person
HC |
CUSIP NO. 28249U105
|
|
|
|
|
|
|
1) |
|
Name of Reporting Person Columbia Management
Investment Advisers, LLC S.S. or I.R.S. Identification No. of Above
Person IRS No. 41-1533211 |
2) |
|
Check the Appropriate Box if a
Member of a Group (a) ☐ (b) ☒*
* This filing describes the reporting persons relationship with other persons, but the reporting
person does not affirm the existence of a group. |
3) |
|
SEC Use Only
|
4) |
|
Citizenship or Place of
Organization
Minnesota |
|
|
|
|
|
|
|
NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5) |
|
Sole Voting Power
0 |
|
6) |
|
Shared Voting Power
0 |
|
7) |
|
Sole Dispositive Power
0 |
|
8) |
|
Shared Dispositive Power
0 |
|
|
|
|
|
|
|
9) |
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0 |
10) |
|
Check if the Aggregate Amount
in Row (9) Excludes Certain Shares Not Applicable |
11) |
|
Percent of
Class Represented by Amount In Row (9) 0.00% |
12) |
|
Type of Reporting Person
IA |
CUSIP NO. 28249U105
|
|
|
|
|
|
|
1) |
|
Name of Reporting Person Columbia Seligman
Technology and Information Fund S.S. or I.R.S. Identification No. of Above
Person IRS No. 13-3154449 |
2) |
|
Check the Appropriate Box if a
Member of a Group (a) ☐ (b) ☒*
* This filing describes the reporting persons relationship with other persons, but the reporting
person does not affirm the existence of a group. |
3) |
|
SEC Use Only
|
4) |
|
Citizenship or Place of
Organization Massachusetts |
NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5) |
|
Sole Voting Power
0 |
|
6) |
|
Shared Voting Power
0 |
|
7) |
|
Sole Dispositive Power
0 |
|
8) |
|
Shared Dispositive Power
0 |
9) |
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0 |
10) |
|
Check if the Aggregate Amount
in Row (9) Excludes Certain Shares Not Applicable |
11) |
|
Percent of
Class Represented by Amount In Row (9) 0.00% |
12) |
|
Type of Reporting Person
IV |
|
|
|
|
|
1(a) |
|
Name of Issuer: |
|
Eiger BioPharmaceuticals, Inc. |
|
|
|
1(b) |
|
Address of Issuers Principal |
|
2155 Park Boulevard |
|
|
Executive Offices: |
|
Palo Alto, CA 94306 |
|
|
|
2(a) |
|
Name of Person Filing: |
|
(a) Ameriprise Financial, Inc. (AFI) |
|
|
|
|
(b) Columbia Management Investment |
|
|
|
|
Advisers, LLC (CMIA) |
|
|
|
|
(c) Columbia Seligman Technology and |
|
|
|
|
Information Fund (Fund) |
|
|
|
2(b) |
|
Address of Principal Business Office: |
|
(a) Ameriprise Financial, Inc. |
|
|
|
|
145 Ameriprise Financial Center |
|
|
|
|
Minneapolis, MN 55474 |
|
|
|
|
(b) 290 Congress St. |
|
|
|
|
Boston, MA 02210 |
|
|
|
|
(c) 290 Congress Street |
|
|
|
|
Boston, MA 02210 |
|
|
|
2(c) |
|
Citizenship: |
|
(a) Delaware |
|
|
|
|
(b) Minnesota |
|
|
|
|
(c) Massachusetts |
|
|
|
2(d) |
|
Title of Class of Securities: |
|
Common Stock |
|
|
|
2(e) |
|
Cusip Number: |
|
28249U204 |
|
|
3 |
|
Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b): |
|
|
|
|
|
(a) Ameriprise Financial, Inc. |
|
|
|
|
|
|
A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7) |
|
|
|
|
(b) Columbia Management Investment Advisers, LLC |
|
|
|
|
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). |
|
|
|
|
(c) Columbia Seligman Technology and Information Fund |
|
|
|
|
An investment company in accordance with Rule 13d-1(b)(1)(ii)(D). |
4 |
Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.
|
CMIA and AFI do not directly own any shares of Common Stock of the issuer. As the investment adviser to the Fund and
various other unregistered and registered investment companies and other managed accounts, CMIA may be deemed to beneficially own the shares reported herein by the Fund. Accordingly, the shares reported herein by CMIA include those shares separately
reported herein by the Fund.
As the parent holding company of CMIA, AFI may be deemed to beneficially own the shares reported
herein by CMIA. Accordingly, the shares reported herein by AFI include those shares separately reported herein by CMIA.
Each of AFI and
CMIA, and the subsidiaries identified on the attached Exhibit I, disclaims beneficial ownership of any shares reported on this Schedule.
5 |
Ownership of 5% or Less of a Class: |
If this statement is being filed to report the fact as of the date hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following (X).
6 |
Ownership of more than 5% on Behalf of Another Person: Not Applicable |
7 |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent
Holding Company: |
AFI: See Exhibit I
8 |
Identification and Classification of Members of the Group: |
Not Applicable
9 |
Notice of Dissolution of Group: |
Not Applicable
By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course
of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such
purposes or effect.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: May 10, 2024
|
|
|
Ameriprise Financial, Inc. |
|
|
By: |
|
/s/ Michael G. Clarke |
Name: Michael G. Clarke |
Title: Senior Vice President, North America Head of
Operations & Investor Services |
|
Columbia Management Investment Advisers, LLC |
|
|
By: |
|
/s/ Michael G. Clarke |
Name: Michael G. Clarke |
Title: Senior Vice President, North America Head of
Operations & Investor Services |
|
Columbia Seligman Technology and Information Fund |
|
|
By: |
|
/s/ Michael G. Clarke |
Name: Michael G. Clarke |
Title: Senior Vice President & Chief Financial
Officer |
|
Contact Information |
Dominic Geddes |
Global Head of Reporting |
Global Operations and Investor Services |
Telephone: +442074645779 |
Exhibit Index
|
|
|
Exhibit I |
|
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company. |
|
|
Exhibit II |
|
Joint Filing Agreement |
Exhibit I
to
Schedule 13G
Ameriprise Financial, Inc., a Delaware Corporation, is a parent holding company. The classification and identity of the relevant subsidiaries is as follows:
Investment Adviser Columbia Management Investment Advisers, LLC is an investment adviser registered under section 203 of the Investment Advisers
Act of 1940.
Exhibit II
to
Schedule 13G
Joint Filing Agreement
The undersigned persons
agree and consent to the joint filing on their behalf of this Schedule 13G dated May 10, 2024 in connection with their beneficial ownership of Eiger BioPharmaceuticals, Inc. Each of Columbia Seligman Technology and Information Fund and Columbia
Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and make any necessary amendments thereto.
Ameriprise Financial, Inc.
|
|
|
By: |
|
/s/ Michael G. Clarke |
Name: Michael G. Clarke |
Title: Senior Vice President, North America Head of Operations & Investor Services
Columbia Management Investment Advisers, LLC
|
|
|
By: |
|
/s/ Michael G. Clarke |
Name: Michael G. Clarke |
Title: Senior Vice President, North America Head of Operations & Investor Services
Columbia Seligman Technology and Information Fund
|
|
|
By: |
|
/s/ Michael G. Clarke |
Name: Michael G. Clarke |
Title: Senior Vice President & Chief Financial Officer
Ameriprise Financial (NYSE:AMP)
Historical Stock Chart
From Apr 2024 to May 2024
Ameriprise Financial (NYSE:AMP)
Historical Stock Chart
From May 2023 to May 2024